BioNTech Secures $110 Million for Rwanda Vaccine Plant

BioNTech secures $110 million for Rwanda vaccine plant

The European Investment Bank and the European Commission provided a financing package of $110 million to German biotechnology company BioNTech for its messenger RNA (mRNA) vaccine manufacturing facility in Rwanda. The World Health Organization estimates that Africa produces only 1% of the vaccines it uses, making it vulnerable to supply shocks. The European investment is geared toward helping the facility, opened in Rwanda in 2023, to become Afr…

BioNTech will get up to €95M in EU funding for a mRNA vaccine site in Africa

Two EU bodies will fund BioNTech with up to €95 million ($110 million) to help build its mRNA vaccine factory in Kigali, Rwanda, which is designed to locally supply vaccines to Africa. The Mainz, Germany ...